Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
We propose a pragmatic, unblinded, randomized controlled, single center trial of 56 pregnant
individuals with Gestational diabetes mellitus (GDM). Our study proposes a pragmatic
randomized control trial of patient led rapid titration of basal insulin compared to standard
therapy. There is a planned subgroup analysis of patients with and without concomitant
metformin usage. Patients will continue routine clinic visits. Patients who are initiated on
basal insulin or started on night-time basal insulin within 7 days will be approached about
the study. Patients who agree to be enrolled will sign informed consent.